TERUMO CORP/ADR (OTCMKTS:TRUMY) Upgraded at ValuEngine

ValuEngine upgraded shares of TERUMO CORP/ADR (OTCMKTS:TRUMY) from a sell rating to a hold rating in a research note released on Thursday, ValuEngine reports.

TRUMY stock opened at $35.95 on Thursday. TERUMO CORP/ADR has a 1 year low of $26.50 and a 1 year high of $36.80. The company has a market cap of $27.20 billion, a P/E ratio of 33.94 and a beta of 0.41. The firm has a 50-day moving average of $33.41 and a 200 day moving average of $30.57. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.67 and a quick ratio of 1.70.

About TERUMO CORP/ADR

Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide. It provides products for use in cardiothoracic surgery, interventional procedure, and medicine transfusion. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems.

Read More: What are catch-up contributions?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for TERUMO CORP/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TERUMO CORP/ADR and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit